Lotronex Action Group
November 20, 2002
Lotronex® Tablets now available
June 7, 2002
FDA Approves Restricted Marketing Of Lotronex
Additional information on Lotronex, including the revised professional and patient labels and physician and patient agreement documents, can be found on the FDA's website at http://www.fda.gov/cder/drug/infopage/lotronex/lotronex.htm
Advisers to the U.S. Food and Drug Administration say the
agency should reverse its decision to ban a drug
 National Public Radio
FDA Advsiory Committee Meeting
LAG and IBS Group member Presentations
IBSGroup.org Poll Results:
What restrictions are IBS sufferers willing to accept for access to IBS medications?
1 2
Open Letter to FDA
Open Letter to GlaxoSmithKline
The Lotronex Action Group seeks immediate access to the medicine Lotronex
(alosetron hydrochloride) while avenues for continued marketing are explored between
GlaxoSmithKline and the Food and Drug Administration. Moreover, the LAG
ultimately seeks permanent access and safe distribution of the medicine to those
diagnosed with IBS-Diarrhea.
The Lotronex Action Group believes the medicine to be safe, if dispensed
properly, and that the benefits of Lotronex far outweigh the potential risk for
adverse side affects.
This website is provided for the purpose of posting accurate and up to date information on efforts to legally bring Lotronex back to the marketplace. The Lotronex Action Group and
its membership does not condone or promote the misuse of this site or
any affiliated sites for any discussion regarding illegal activity.
The Lotronex Action Group was organized by members of the IBS Self Help Group and former Lotronex users. The Lotronex Action Group is not affiliated nor receives any funding from any pharmaceutical company.
Main
| About Us | Petition | Physician Letter
| LAG News
Press
| Links
| Industry
Contacts
|
